Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus is a research paper published in Molecular Therapy β Methods & Clinical Development (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
The Royal Society
Grant: RG\u2216R1\u2216241347
Leukemia and Lymphoma Society
Grant: 3385-19
Japan Society for the Promotion of Science
Grant: K99HL150218
National Institutes of Health
Grant: R01DK116944
National Institutes of Health
Grant: R01HL147124
National Science Foundation
Grant: DGE-1656518
FWCI
3.53
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals